Informed consent has been defined as "an ... that physicians also consider how they act when they give information to a potential research participant.
A-319 is under clinical development by ITabMed and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData, Phase I drugs for Systemic Lupus Erythematosus have a 73% phase ...
Psilocybin is under clinical development by Silo Pharma and currently in Phase II for Parkinson’s Disease. According to GlobalData, Phase II drugs for Parkinson’s Disease have a 41% phase transition ...